Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

DRUG(1)

Algucosidase alfa 20 mg/kg once every 4 weeks instead of once every 2 weeks

1 trial

phase_4

erasmus-medical-center

1 unique interventions1 categories

Analytics

Trial Phases

Phase 41

Trial Status

Other1

Role Distribution

Principal Investigator1

PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06575829Phase 4Not Yet Recruiting

Treatment Frequency Reduction in Pompe Disease

Acid Maltase DeficiencyGAA DeficiencyGlycogen Storage Disease Type II+1 more

Principalinvestigator

Research Network

Collaboration Network

3 collaborators·3 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Acid Maltase Deficiency1 Glycogen Storage Disease Type II1 Pompe Disease Late-Onset1

Affiliations

Erasmus Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Tim Preijers, Dr.

Erasmus Medical Center

Moderately Similar

1 trials

Shared therapeutic areas:

Acid Maltase DeficiencyGlycogen Storage Disease Type IIPompe Disease Late-Onset

Worked with same sponsors:

Erasmus Medical Center

Collaborated on 1 trial

Similarity Score34%

Pieter A. van Doorn, Prof. dr.

Erasmus Medical Center

Moderately Similar

1 trials

Shared therapeutic areas:

Acid Maltase DeficiencyGlycogen Storage Disease Type IIPompe Disease Late-Onset

Worked with same sponsors:

Erasmus Medical Center

Collaborated on 1 trial

Similarity Score34%

Tahseen Mozaffar, MD

University of California Irvine Health

Moderately Similar

2 trials

Shared therapeutic areas:

Acid Maltase DeficiencyGlycogen Storage Disease Type IIPompe Disease Late-Onset

Similarity Score30%

Paolo Banfi, MD

IRCCS Fondazione Don Carlo Gnocchi

1 trials

Shared therapeutic areas:

Glycogen Storage Disease Type IIPompe Disease Late-Onset

Similarity Score20%

Regina Trollmann, MD

University Hospital Erlangen

1 trials

Shared therapeutic areas:

Glycogen Storage Disease Type IIPompe Disease Late-Onset

Similarity Score20%

Priya Kishnani, MD

Duke University

8 trials

Shared therapeutic areas:

Glycogen Storage Disease Type IIPompe Disease Late-Onset

Similarity Score20%

Ferdinand Knieling, MD

University Hospital Erlangen

2 trials

Shared therapeutic areas:

Glycogen Storage Disease Type IIPompe Disease Late-Onset

Similarity Score20%

Priya Kishnani

Duke University

1 trials

Shared therapeutic areas:

Glycogen Storage Disease Type II

Similarity Score10%

Benedikt Schoser, MD

Friedrich-Baur-Institute, Dep. of Neurology Klinikum der Universitaet Muenchen Munich, Germany

2 trials

Shared therapeutic areas:

Glycogen Storage Disease Type II

Similarity Score10%

Dwight d Koeberl, MD, PhD

Duke University

3 trials

Shared therapeutic areas:

Glycogen Storage Disease Type II

Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06575829Phase 4PrincipalInvestigator

Treatment Frequency Reduction in Pompe Disease

Acid Maltase DeficiencyGAA DeficiencyGlycogen Storage Disease Type II+1 more

Not Yet Recruiting

All 1 trials loaded